Publication | Closed Access

Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients

ThrombosisIll PatientsLinezolid-associated ThrombocytopeniaTherapeutic Drug MonitoringVenous ThrombosisMedicineHematologyPatient SafetySepsisDrug MonitoringPharmacotherapyPlatelet AntagonistLaboratory MedicineAnticoagulant